Boston Bio Systems Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 0.18 | 0.19 | TBA |
| Operating Expense | 0.09 | 0.68 | 0.05 |
| Net Profit | 0.04 | -0.49 | -0.05 |
| Net Profit Margin | 22.22 | -257.89 | TBA |
| Earning Per Share | 0.06 | -0.70 | -0.07 |
| EBIDTA | 0.08 | -0.49 | -0.05 |
| Effective Tax Rate | 11.11 | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 0.18 |
| Operating Expense | 0.09 |
| Net Profit | 0.04 |
| Net Profit Margin | 22.22 |
| Earning Per Share | 0.06 |
| EBIDTA | 0.08 |
| Effective Tax Rate | 11.11 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 0.19 | TBA | TBA |
| Operating Expenses Annual | 0.74 | 0.14 | 0.00 |
| Operating Profit Annual | -0.55 | -0.14 | -0.00 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | TBA | TBA | TBA |
| Net Profit Annual | -0.55 | -0.14 | -0.00 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 0.19 |
| Operating Expenses Annual | 0.74 |
| Operating Profit Annual | -0.55 |
| Interest Annual | TBA |
| Depreciation | TBA |
| Net Profit Annual | -0.55 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.05 | 0.05 | 0.05 |
| Cash Flow from Operations | -4.59 | TBA | TBA |
| Cash Flow from Investing | TBA | TBA | TBA |
| Cash Flow from Financing | 4.58 | TBA | TBA |
| Cash Flow at the End | 0.04 | 0.05 | 0.05 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.05 |
| Cash Flow from Operations | -4.59 |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | 4.58 |
| Cash Flow at the End | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -289.47 | TBA | TBA |
| PBIT Margin (%) | -289.47 | TBA | TBA |
| PBT Margin (%) | -289.47 | TBA | TBA |
| Net PROFIT Margin (%) | -289.47 | TBA | TBA |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -5.79 | TBA | TBA |
| Total Debt / Equity (X) | 0.51 | 0.13 | 0.13 |
| Asset Turnover Ratio (%) | 0.02 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -289.47 |
| PBIT Margin (%) | -289.47 |
| PBT Margin (%) | -289.47 |
| Net PROFIT Margin (%) | -289.47 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -5.79 |
| Total Debt / Equity (X) | 0.51 |
| Asset Turnover Ratio (%) | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | TBA |
| Total Current Assets Annual | 9.11 | 4.77 | 4.77 |
| Non Current Assets Annual | 5.79 | 5.79 | 5.79 |
| Total Shareholders Funds Annual | 5.90 | 6.45 | 6.59 |
| Total Assets Annual | 14.90 | 10.57 | 10.57 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | 9.11 |
| Non Current Assets Annual | 5.79 |
| Total Shareholders Funds Annual | 5.90 |
| Total Assets Annual | 14.90 |
No Data Availabe
